logo-loader
RNS
Reckitt Benckiser

Directorate Change

/**/ link{ color: #0563C1 }visited{ color: #954F72 } .r{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.r{}p.ai{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align: right}span.ag{font-size: 14.0pt;line-height:107%}p.aj{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; text-align: center}span.ae{font-size:16.0pt;line-height:107%}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";}span.ac{font-size:14.0pt;line-height:107%}p.ak{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold}p.al{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:15.4pt;margin-right:0cm;margin-bottom: 15.4pt;margin-left:0cm} span.aa{font-size:14.0pt;line-height:107%; color:black}p.p,li.p,div.p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}span.am{font-size:14.0pt;font-family:"Calibri","sans-serif"}span.x{font-size:14.0pt; font-family:"Calibri","sans-serif"}p.an{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-weight: bold; margin-bottom: 11.25pt; margin-left: 0cm; margin-right: 0cm; margin-top: 15.4pt}span.w{font-size:14.0pt; color:#4A4A4A}p.ao{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:15.4pt;margin-right:0cm;margin-bottom: 0cm;margin-left:0cm;margin-bottom:.0001pt;background:white}.t{text-decoration: underline}span.u{font-size:14.0pt;color:#4A4A4A} /**/
RNS Number : 7376X
Reckitt Benckiser Group PLC
01 May 2019
 

 

Sara Mathew to join RB Board, bringing deep knowledge of consumer goods and digital technologies

 

1 May 2019, Slough UK - Reckitt Benckiser Group plc is pleased to announce the appointment of Sara Mathew to the Board as a non-executive director, effective 1 July 2019. She will also join the Audit Committee of the Board at the same time.

Most recently Ms Mathew was Chairman and Chief Executive Officer of Dun & Bradstreet, a company providing commercial data, analytics and insights for businesses.  In this role, she led a transformation of the company into an innovative digital enterprise, leveraging technology to enhance both data quality and coverage.  Prior to this role, Ms Mathew served as President and Chief Operating Officer, and before that, she was Chief Financial Officer.

Prior to her career at Dun & Bradstreet, Ms Mathew had an 18-year career at Procter & Gamble serving as CFO of the Baby Care and Paper Products businesses and Vice President of Finance in Asia.

Ms Mathew has extensive board experience across a number of industries including healthcare, consumer products and financial services.  Previously, she served on the boards of Shire Pharmaceuticals, Campbell Soup Company and Avon.  Currently Ms Mathew is on the board of State Street Bank and is Chair of the Board of Freddie Mac, the US home loan company.

Ms Mathew received her undergraduate degree from the University of Madras in Chennai, India and holds a Master of Business Administration in marketing and finance from Xavier University in Cincinnati, Ohio.

Commenting on the appointment, Chris Sinclair, Chairman of the Board said "I am delighted that Sara has agreed to join the Board.  She has extensive experience with consumer goods products, digital technologies and healthcare and has led strategic and digital transformations.   Sara will bring great insight to the Board and we welcome her appointment."

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Sara Mathew's appointment.

About RB

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. 

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. 

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. 

For more information visit www.rb.com

 *RB is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

For further information, please contact:

Reckitt Benckiser                                                                          +44 (0)1753 217800

Patty O'Hayer, James Fearnley-Marr

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOAUGUWCAUPBUBG

Quick facts: Reckitt Benckiser

Price: £61.70

Market: LSE
Market Cap: £43.75 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Director/PDMR Shareholding

1 week, 4 days ago

Total Voting Rights

2 weeks, 2 days ago

Half Year Results 2019

2 weeks, 4 days ago

Directorate Change

2 weeks, 5 days ago

RB CEO Announcement

on 12/6/19